The Cooper Companies, Inc. (COO)
Stock Price Chart
Key Info
| Market Cap | 16.02B |
| Revenue (ttm) | 2.54B |
| Net Income (ttm) | 343.10M |
| Shares Out | 53.33M |
| EPS (ttm) | 6.87 |
| PE Ratio | 43.71 |
| Forward PE | 24.69 |
| Dividend | $0.06 |
| Dividend Yield | 0.02% |
Stock Quote
| Trading Day | Aug 11, 2020 |
| Last Price | $300.31 |
| Previous Close | $306.83 |
| Change ($) | -6.52 |
| Change (%) | -2.12% |
| Day's Open | 308.33 |
| Day's Range | 299.18 - 308.57 |
| Day's Volume | 320,535 |
| 52-Week Range | 236.68 - 365.68 |
More Stats
| Market Cap | 16.02B |
| Enterprise Value | 18.10B |
| Earnings Date (est) | Sep 3, 2020 |
| Ex-Dividend Date | Jul 22, 2020 |
| Shares Outstanding | 53.33M |
| Float | 48.77M |
| EPS (basic) | 6.94 |
| EPS (diluted) | 6.87 |
| FCF / Share | 4.75 |
| Dividend | $0.06 |
| Dividend Yield | 0.02% |
| Earnings Yield | 2.29% |
| FCF Yield | 1.46% |
| Payout Ratio | 0.90% |
| Shares Short | 860,006 |
| Short Ratio | 1.83 |
| Short % of Float | 2.06% |
| Beta | 0.88 |
| PE Ratio | 43.71 |
| Forward PE | 24.69 |
| P/FCF Ratio | 68.56 |
| PS Ratio | 6.30 |
| PB Ratio | 4.42 |
| Revenue | 2.54B |
| Operating Income | 428.50M |
| Net Income | 343.10M |
| Free Cash Flow | 233.60M |
| Net Cash | -2.08B |
| Net Cash / Share | -39.07 |
| Gross Margin | 69.11% |
| Operating Margin | 16.86% |
| Profit Margin | 13.50% |
| FCF Margin | 9.19% |
| ROA | 4.30% |
| ROE | 9.57% |
| ROIC | 12.20% |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,653 | 2,533 | 2,139 | 1,967 | 1,797 | 1,718 | 1,588 | 1,445 | 1,331 | 1,159 |
| Revenue Growth | 4.76% | 18.41% | 8.76% | 9.44% | 4.62% | 8.19% | 9.87% | 8.59% | 14.87% | - |
| Gross Profit | 1,757 | 1,632 | 1,366 | 1,173 | 1,070 | 1,092 | 1,027 | 924 | 805 | 677 |
| Operating Income | 547 | 403 | 429 | 324 | 237 | 306 | 341 | 288 | 228 | 162 |
| Net Income | 467 | 140 | 373 | 274 | 204 | 270 | 296 | 248 | 175 | 113 |
| Shares Outstanding | 49.40 | 49.10 | 48.90 | 48.50 | 48.50 | 48.06 | 48.62 | 47.91 | 46.90 | 45.53 |
| Earnings Per Share | 9.33 | 2.81 | 7.52 | 5.59 | 4.14 | 5.51 | 5.96 | 5.05 | 3.63 | 2.43 |
| EPS Growth | 232.03% | -62.63% | 34.53% | 35.02% | -24.86% | -7.55% | 18.02% | 39.12% | 49.38% | - |
| Dividend Per Share | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Dividend Growth | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | - |
| Operating Cash Flow | 713 | 669 | 594 | 510 | 391 | 455 | 416 | 315 | 336 | 268 |
| Capital Expenditures | -292 | - | -127 | -153 | -243 | -238 | -178 | -99.78 | -104 | -73.76 |
| Free Cash Flow | 421 | 669 | 466 | 357 | 148 | 217 | 238 | 215 | 233 | 194 |
| Cash & Equivalents | 89.00 | 77.70 | 88.80 | 101 | 16.43 | 25.22 | 77.39 | 12.84 | 5.18 | 3.57 |
| Total Debt | 1,826 | 2,023 | 1,173 | 1,334 | 1,349 | 1,382 | 345 | 374 | 380 | 611 |
| Net Cash / Debt | -1,737 | -1,945 | -1,084 | -1,233 | -1,333 | -1,357 | -267 | -361 | -375 | -608 |
| Assets | 6,275 | 6,113 | 4,859 | 4,479 | 4,460 | 4,458 | 3,137 | 2,941 | 2,625 | 2,525 |
| Liabilities | 2,646 | 2,805 | 1,683 | 1,783 | 1,786 | 1,870 | 714 | 728 | 687 | 858 |
| Book Value | 3,628 | 3,308 | 3,176 | 2,696 | 2,668 | 2,570 | 2,405 | 2,193 | 1,937 | 1,667 |
Company Profile
Company Details
| Full Name | The Cooper Companies, Inc. |
| Country | United States |
| Employees | 12,000 |
| CEO | Albert George White |
Stock Information
| Ticker Symbol | COO |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Unique Identifier | NYSE: COO |
Description
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive option, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is based in San Ramon, California.